Highlights
- 1Nature communications · 2022
- 2Nature communications · 2024
- 3
Publications
71 publications
Funding
9 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- PIPreliminary study of exosome treatment in an acute dry age-related macular degeneration (AMD) mouse model3D Global Biotech INC · 2026–2028ContractSRA 261588-01
- PIEndosome regulated retinal homeostasis and diseaseNational Eye Institute · 2018–2027· 2 renewalsR01EY029428-08
- PIModeling and mechanistic investigation of a novel dry AMD mouse model with CLIC4 deleted in RPENational Eye Institute · 2021–2026R01EY032966-04
Completed grants (6)
- PIMaking cone-rich retinas in dishes by manipulating ciliary dynamics and cell divisionAlcon Laboratories, Inc. · 2017–2021ARI 180814-03
- PIControl of Retinal Neurogenesis by Cilium-Mediated Cell Cycle Progression and Cell Fate ChoiceResearch to Prevent Blindness, Inc. · 2016–2019RPB 17020218-03
- PIStrategy and Development of New Drug Development and Macular Degeneration Treatment for Macular Diseases with High Throughput Screening Drug SystemKaohsiung Medical University · 2018–2019ContractSRA 183224-01
- PIStructural and Functional Integrity and Microenvironment of RPE CellsNational Eye Institute · 2012–2017
- PIMolecular Basis of Protein Transport in PhotoreceptorNational Eye Institute · 2011–2016
Available technologies
3 technologiesView full WCM portfolio ↗
News mentions
2 mentionsView all WCM news ↗
- Preclinical Model Offers New Insights into Parkinson’s Disease ProcessJuly 23, 2024
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease in people, according to a study led by Weill Cornell Medicine researchers.
- Pre-Clinical Model May Enable Development of New Treatments for Leading Cause of Age-Related Vision LossJanuary 18, 2022
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, called dry age-related macular degeneration (dry AMD), and used it to identify new treatment modalities and drug targets.
Mentoring
1 mentee
- RJRuben JaureguiMD mentee · Class of 2019